ID
28152
Descripción
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Investigational product
Palabras clave
Versiones (4)
- 21/9/17 21/9/17 -
- 13/10/17 13/10/17 -
- 23/10/17 23/10/17 -
- 22/12/17 22/12/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
22 de diciembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
Descripción
Investigational product discontinuation
Descripción
investigational product stopped permanently
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0457454
Descripción
Select "Protocol deviation" if none of the other primary reasons are appropriate. Select "Decision by subject or proxy" if none of the other primary reasons are appropriate. In case of "Adverse Event", record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons".
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0457454
Descripción
Record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate. Check all that apply. If none, select "No Subreasons":
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2699517
Descripción
Adverse event MACE
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1516728
- UMLS CUI [1,2]
- C2826934
Descripción
Select this reason if none of the other primary reasons are appropriate.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1705236
Descripción
Select this reason if none of the other primary reasons are appropriate.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0679006
Descripción
Sponsor terminated study treatment specification
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1710224
Descripción
Investigator site closed specification
Tipo de datos
text
Alias
- UMLS CUI [1]
- C2348235
Descripción
Post-IP Follow-up status
Descripción
Select type [1] if telephone follow-up was accepted by subject. Please complete TELE visit form for each contact. In case of type [2], please complete THIRD PARTY visit form for each contact. In case of type [3], please complete CONC form within EOS visit.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0589121
- UMLS CUI [1,2]
- C0205272
Descripción
Fill in in case "Post-IP Phone Follow-up With Subject" or "Post-IP Follow-up through designated third party" has been selected.
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3476109
Descripción
Contact frequency other
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0337611
Descripción
Authorization status
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0680281
- UMLS CUI [1,2]
- C0018724
Similar models
Investigational product GSK study Chronic Coronary Heart Disease NCT00799903
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C2826934 (UMLS CUI [1,2])
C0679006 (UMLS CUI [1,2])
C0205272 (UMLS CUI [1,2])
C0018724 (UMLS CUI [1,2])